• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于位于同一肝段的单个大肝细胞癌,肝切除术与更好的预后相关。

Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.

作者信息

Zhang Wei, Tan Yongqiong, Jiang Li, Yan Lunan, Li Bo, Wen Tianfu, Yang Jiayin

机构信息

Department of Liver Surgery, Liver Transplantation Center Center for Operating Room and Anesthesia, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.

出版信息

Medicine (Baltimore). 2017 Mar;96(10):e6246. doi: 10.1097/MD.0000000000006246.

DOI:10.1097/MD.0000000000006246
PMID:28272222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5348170/
Abstract

The influence of the anatomical location of single large hepatocellular carcinoma (HCC) on outcomes following hepatic resection (HR) is still unclear. This study examined the role of anatomical location profiles as prognostic markers for patients with single large HCC undergoing HR.A total of 374 consecutive patients with single large HCC undergoing HR between January 2009 and July 2013 were included. They were divided into group same section (SS) group (n = 171) and different sections (DS) group (n = 203) according to their tumor's anatomical location. Short- and long-term outcomes were compared between the two groups.More patients in group DS had intraoperative blood loss of >1000 mL and needed intraoperative blood transfusion than those in group SS. There were no significant differences regarding postoperative complications and 30-and 90-day mortality between the two groups. The overall survival (OS) and recurrence-free survival (RFS) rates were significantly higher in group SS than group DS. The subgroup analysis showed that tumor in the same section was associated with better prognosis than those in different sections for both patients with tumor of ≤8 cm and of > 8 cm. Multivariate analysis revealed that age <60 years, portal hypertension, alpha-fetoprotein ≥400 ng/mL, tumor in different sections, microvascular invasion and poorly differentiated tumor are independent predictors of poor prognosis in patient with single large HCC.For patients with single large HCC, a tumor located in the same section may lead to better long-term survival and lower tumor recurrence rates than those in different sections following HR.

摘要

单个大肝细胞癌(HCC)的解剖位置对肝切除术后(HR)预后的影响仍不清楚。本研究探讨了解剖位置特征作为接受HR的单个大HCC患者预后标志物的作用。

纳入了2009年1月至2013年7月期间连续接受HR的374例单个大HCC患者。根据肿瘤的解剖位置,将他们分为同肝段(SS)组(n = 171)和不同肝段(DS)组(n = 203)。比较两组的短期和长期预后。

DS组术中失血>1000 mL且需要术中输血的患者比SS组更多。两组术后并发症以及30天和90天死亡率方面无显著差异。SS组的总生存期(OS)和无复发生存期(RFS)率显著高于DS组。亚组分析显示,对于肿瘤≤8 cm和>8 cm的患者,同肝段肿瘤的预后均优于不同肝段肿瘤。多因素分析显示,年龄<60岁、门静脉高压、甲胎蛋白≥400 ng/mL、不同肝段肿瘤、微血管侵犯和低分化肿瘤是单个大HCC患者预后不良的独立预测因素。

对于单个大HCC患者,与不同肝段肿瘤相比,同肝段肿瘤在HR后可能导致更好的长期生存和更低的肿瘤复发率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/6a972a32ccc8/medi-96-e6246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/6cfe3596d26c/medi-96-e6246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/227215e7dd70/medi-96-e6246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/3e17d612d69c/medi-96-e6246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/6a972a32ccc8/medi-96-e6246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/6cfe3596d26c/medi-96-e6246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/227215e7dd70/medi-96-e6246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/3e17d612d69c/medi-96-e6246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a7/5348170/6a972a32ccc8/medi-96-e6246-g006.jpg

相似文献

1
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.对于位于同一肝段的单个大肝细胞癌,肝切除术与更好的预后相关。
Medicine (Baltimore). 2017 Mar;96(10):e6246. doi: 10.1097/MD.0000000000006246.
2
Multiple Tumors Located in the Same Section Are Associated with Better Outcomes After Hepatic Resection for HCC Patients Meeting the Milan Criteria.对于符合米兰标准的肝癌患者,同一肝段内的多个肿瘤与肝切除术后更好的预后相关。
J Gastrointest Surg. 2015 Dec;19(12):2207-14. doi: 10.1007/s11605-015-2959-0. Epub 2015 Sep 22.
3
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
4
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.多中心队列研究:肝切除治疗双叶型肝细胞肝癌的长期生存结果。
Oncologist. 2019 Aug;24(8):e730-e739. doi: 10.1634/theoncologist.2018-0898. Epub 2019 May 24.
5
Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.无肉眼可见血管侵犯的孤立性肝细胞癌的解剖性切除与非解剖性切除:一项倾向评分匹配分析
J Gastroenterol Hepatol. 2017 Apr;32(4):870-878. doi: 10.1111/jgh.13603.
6
Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.肝切除术对部分中晚期肝细胞癌患者而言可带来良好的生存期。
Ann Surg. 2014 Aug;260(2):329-40. doi: 10.1097/SLA.0000000000000236.
7
Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
J Formos Med Assoc. 2008 Aug;107(8):616-26. doi: 10.1016/S0929-6646(08)60179-5.
8
Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes.针对位于肝脏中央的大型肝细胞癌的肝中叶切除术:适应症、技术及结果
Surgery. 2014 Nov;156(5):1177-87. doi: 10.1016/j.surg.2014.05.012. Epub 2014 Oct 17.
9
Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.肿瘤-基质比是肝细胞癌患者肝切除或移植后生存的一个预后因素。
Surgery. 2015 Jul;158(1):142-50. doi: 10.1016/j.surg.2015.02.013. Epub 2015 Apr 15.
10
Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.巨大肝细胞癌肝切除术后的长期结果:中国单中心经验。
Hepatobiliary Pancreat Dis Int. 2019 Dec;18(6):532-537. doi: 10.1016/j.hbpd.2019.09.001. Epub 2019 Sep 11.

引用本文的文献

1
Hepatocellular carcinoma grading and recurrence prediction using T mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.利用钆乙氧基苄基二乙三胺五乙酸增强磁共振成像上的T映射对肝细胞癌进行分级和复发预测
Oncol Lett. 2019 Sep;18(3):2322-2329. doi: 10.3892/ol.2019.10557. Epub 2019 Jul 4.
2
Prognostic Factors and Survival Outcomes of Surgical Resection of Huge Hepatocellular Carcinomas.巨大肝细胞癌手术切除的预后因素及生存结果
J Gastrointest Cancer. 2020 Mar;51(1):250-253. doi: 10.1007/s12029-019-00240-x.
3
Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection.

本文引用的文献

1
Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.术前血清甲胎蛋白与肝癌肝切除术后的预后。
Br J Surg. 2016 May;103(6):716-724. doi: 10.1002/bjs.10093. Epub 2016 Mar 21.
2
Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.肝细胞癌根治性肝切除术后的早期复发危险因素及模式
Surg Oncol. 2016 Mar;25(1):24-9. doi: 10.1016/j.suronc.2015.12.002. Epub 2015 Dec 12.
3
High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization.
术前高敏C反应蛋白与淋巴细胞比值指数对肝细胞癌手术切除后的预后起着至关重要的作用。
Onco Targets Ther. 2018 Sep 7;11:5591-5600. doi: 10.2147/OTT.S167857. eCollection 2018.
4
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case-control study.在大型肝细胞癌中,激光消融优于经动脉化疗栓塞术:一项初步病例对照研究。
Oncotarget. 2018 Apr 3;9(25):17483-17490. doi: 10.18632/oncotarget.24756.
高血小板计数增加巨大肝细胞癌经动脉化疗栓塞术后转移风险。
Hepatol Res. 2016 Sep;46(10):1028-36. doi: 10.1111/hepr.12651. Epub 2016 Mar 10.
4
Effect of age on survival in patients undergoing resection of hepatocellular carcinoma.年龄对肝癌切除术患者生存的影响。
Br J Surg. 2016 Jan;103(2):e93-9. doi: 10.1002/bjs.10056. Epub 2015 Dec 10.
5
Multiple Tumors Located in the Same Section Are Associated with Better Outcomes After Hepatic Resection for HCC Patients Meeting the Milan Criteria.对于符合米兰标准的肝癌患者,同一肝段内的多个肿瘤与肝切除术后更好的预后相关。
J Gastrointest Surg. 2015 Dec;19(12):2207-14. doi: 10.1007/s11605-015-2959-0. Epub 2015 Sep 22.
6
Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.符合巴塞罗那临床肝癌分期A类标准的多灶性肿瘤肝细胞癌患者肝切除与射频消融治疗效果的比较
J Am Coll Surg. 2015 Nov;221(5):951-61. doi: 10.1016/j.jamcollsurg.2015.08.009. Epub 2015 Aug 20.
7
Age is no longer a limit: two cases of hepatectomy in patients over 90 years old.年龄不再是限制:两例90岁以上患者的肝切除术病例。
Case Rep Gastroenterol. 2015 Feb 10;9(1):49-55. doi: 10.1159/000368115. eCollection 2015 Jan-Apr.
8
Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes.针对位于肝脏中央的大型肝细胞癌的肝中叶切除术:适应症、技术及结果
Surgery. 2014 Nov;156(5):1177-87. doi: 10.1016/j.surg.2014.05.012. Epub 2014 Oct 17.
9
Incidence and mortality of liver cancer in China, 2010.2010年中国肝癌的发病率和死亡率
Chin J Cancer. 2014 Aug;33(8):388-94. doi: 10.5732/cjc.014.10088. Epub 2014 Jul 11.
10
Treatment of intermediate-stage hepatocellular carcinoma.中晚期肝细胞癌的治疗。
Nat Rev Clin Oncol. 2014 Sep;11(9):525-35. doi: 10.1038/nrclinonc.2014.122. Epub 2014 Aug 5.